Request More Information
Clinical Test Menu
*for research only — Validation pending
Immunotherapy is a promising new cancer treatment approach. In order to develop effective precision immunotherapies, it is important to identify immune checkpoint targets and the types and locations of immune cells in the tumor microenvironment; e.g., B cells, T cells, others. The MultiOmyx Tumor Infiltrating Lymphocyte Panel provides the ideal solution – quantitative analytical results from every cell on your single FFPE slide.
Tumor Infiltrating Lymphocyte Panel Data Sheet
Hyperplex Immunofluorescence (IF) Assay
MultiOmyx Integrated multi “Omic” assays